Effects of sumatriptan on cerebral blood flow under normo- and hypercapnia in rats

Cephalalgia

Volumn 22, Issue 6, 2002, Pages 468-473

  Fukuda, Michinari ^a,b   Suzuki, N ^a   Maruyama, S ^a   Dobashi, K ^a   Kitamura, A ^a   Sakai, F ^a  

^a KITASATO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Cerebral blood flow; Hypercapnia; Migraine attack; Serotonin receptor; Sumatriptan

Indexed keywords

CR 43175C; SEROTONIN 1B RECEPTOR; SUMATRIPTAN SUCCINATE; SUMATRIPTAN; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; CARBON DIOXIDE BREATHING; CONTROLLED STUDY; CORPUS STRIATUM; DRUG MECHANISM; DRUG RECEPTOR BINDING; HYPERCAPNIA; MALE; MIGRAINE; NONHUMAN; PARIETAL LOBE; RAT; VASCULAR SMOOTH MUSCLE; VASOCONSTRICTION; ANIMAL; DRUG EFFECT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; VASCULARIZATION;

ANIMALS; CEREBROVASCULAR CIRCULATION; CORPUS STRIATUM; HYPERCAPNIA; MALE; MIGRAINE DISORDERS; MUSCLE, SMOOTH, VASCULAR; PARIETAL LOBE; RATS; RATS, SPRAGUE-DAWLEY; SUMATRIPTAN; VASOCONSTRICTION; VASOCONSTRICTOR AGENTS;

EID: 0036632609     PISSN: 03331024     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1468-2982.2002.00395.x     Document Type: Article

References (30)

1. Ray BS,Wolff HG. Experimental studies on headache. Arch Surg 1949; 41:813-56.
2. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol 1981; 9:344-52.
3. Moskowitz MA. The neurobiology of vascular head pain. Ann Neurol 1984; 16:157-68.
4. Sakai F, Meyer JS. Abnormal cerebrovascular reactivity in patients with migraine and cluster headache. Headache 1979; 19:257-66.
5. Lauritzen M, Olsen TS, Lassen NA, Paulson OB. Regulation of regional cerebral blood flow during and between migraine attacks. Ann Neurol 1983; 14:569-72.
6. Perrin VL, Färkkilä M, Goasguen J, Doenicke A, Brand J, Tfelt-Hansen P. Overview of initial clinical studies with intravenous and oral GR43175 in acute migraine. Cephalalgia 1989; 9 (Suppl. 9):63-72.
7. 1-like receptor agonist, for the acute treatment of severe migraine. Lancet 1988; 1:1309-11.
8. Oral Sumatriptan Dose-Defining Study Group. Sumatriptan - an oral dose-defining study. Eur Neurol 1991; 31:300-5.
9. Findley LJ, Abbas A, Bayliss EM. The acute treatment of migraine with aura with sumatriptan. Cephalalgia 1991; 11:226-7.
10. Goadsby PJ, Zagami AS, Donnan GA, Symington G, Anthony M, Bladin PF et al. Oral sumatriptan in acute migraine. Lancet 1991; 338:782-3.
11. Multinational Oral Sumatriptan and Cafergot Comparative Study Group. A randomized, double blind comparison of sumatriptan and cafergot in the acute treatment of migraine. Eur Neurol 1991; 31:314-22.
12. Ensink F-BM. Subcutaneous sumatriptan in the acute treatment of migraine. J Neurol 1991; 238:S66-S69.
13. Subcutaneous Sumatriptan International Study Group. Treatment of migraine attacks with sumatriptan. N Engl J Med 1991; 325:316-21.
14. Finnish Sumatriptan Group and the Cardiovascular Clinical Research Group. A placebo-controlled study of intranasal sumatriptan for the acute treatment of migraine. Eur Neurol 1991; 31:332-8.
15. Skingle M, Birch PJ, Leighton GE, Humphrey PPA. Lack of antinociceptive activity of sumatriptan in rodents. Cephalalgia 1990; 10:207-12.
16. 14C-GR43175 in rat and dog. Cephalalgia 1989; 9 (Suppl. 9):53-6.
17. Sleight AJ, Cervenka A, Peroutka SJ. In vivo effects of sumatriptan (GR 43175) on extracellular levels of 5-HT in the guinea pig. Neuropharmacology 1990; 29:511-3.
18. 1-like receptor agonists and the pathophysiology of migraine. Trends Pharmacol Sci 1989; 10:200-4.
19. Skarphedinsson JO, Hårding H, Thorén P. Repeated measurements of cerebral blood flow in rats. Comparisons between the hydrogen clearance method and laser Doppler flowmetry. Acta Physiol Scand 1988; 134:133-42.
20. Ullmer C, Schmuck K, Kalkman HO, Lübbert H. Expression of serotonin receptor mRNAs in blood vessels. FEBS Letters 1995; 370:215-21.
21. Cohen Z, Bouchelet I, Olivier A, Villemure J-G, Ball R, Stanimirovic DB et al. Multiple microvascular and astroglial 5-hydroxytryptamine receptor subtypes in human brain: molecular and pharmacological characterization. J Cereb Blood Flow Metab 1999; 19:908-17.
22. Hoyer D, Clarke DE, Forzard JR, Hartig PR, Martin GR, Mylecharane EJ et al. VII International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (Serotonin). Pharmacol Rev 1994; 46:157-203.
23. Perren MJ, Feniuk W, Humphrey PPA. The selective closure of feline carotid arteriovenous anastomoses (AVAs) by GR43175. Cephalalgia 1989; 9 (Suppl. 9):41-6.
24. 1-like receptor agonist, on pial vessel diameter in anaesthetised cats. J Cereb Blood Flow Metab 1992; 12:514-9.
25. Kobari M, Fukuuchi Y, Tomita M, Tanahashi N, Konno S, Takeda H. Effects of sumatriptan on the cerebral intraparenchymal microcirculation in the cat. Br J Pharmacol 1993; 110:1445-8.
26. Ebihara A, Ohashi K, Fujimura A, Kumagai Y, Ohira H, Shiga T et al. Phase I study of sumatriptan injection (The 2nd report) - Single- and multiple-subcutaneous dose study in Japanese healthy subjects. J Clin Ther Med 1993; 9:767-76.
27. Parent A. Meninges and cerebrospinal fluid. In: Carpenter's human neuroanatomy, 9th edn. Baltimore: Williams & Wilkins, 1996:3-24.
28. 1B/1D receptor: a central action in migraine? Ann Neurol 1998; 43:711-8.
29. 1B/1D) agonists in a model of trigeminovascular nociception in cat. Exp Neurol 1998; 150:45-51.
30. Oliver DW, Dormehl IC, Hugo N. Effect of sumatriptan on cerebral blood flow in the baboon model. Arzneim. Forsch./Drug Res 1994; 44:925-8.